Are lutein and zeaxanthin conditionally essential nutrients for eye health?

Medical Hypotheses

Volumn 61, Issue 4, 2003, Pages 465-472

  Semba, R D ^a,b   Dagnelie, G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENOID; REACTIVE OXYGEN METABOLITE; XANTHOPHYLL; ZEAXANTHIN;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; ENERGY; EYE; HEALTH STATUS; HUMAN; NUTRIENT; OXIDATIVE STRESS; PATHOGENESIS; PHOTORECEPTOR; PRIMATE; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW;

PRIMATES;

EID: 0344736659     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00198-1     Document Type: Article

References (77)

1. Pfander H. Carotenoids: an overview. Methods Enzymol 1992; 213: 3-13.
2. Sommerburg O., Keunen J. E. E., Bird A. C., van Kiujk F. J. G. M. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998; 82: 907-910.
3. Holden J. M., Eldridge A. L., Beecher G. R. et al. Carotenoid content of US foods: an update of the database. J Food Comp Anal 1998; 12: 169-196.
4. Seddon J. M., Ajani U. A., Sperduto R. D., Hiller R., Blair N., Burton T. C. et al. Dietary carotenoids, vitamins A, C, and E and advanced age-related macular degeneration. J Am Med Assoc 1994; 272: 1413-1420.
5. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
6. Harper A. E. Defining the essentiality of nutrients. In: M. E. Shils, J. A. Olson, M. Shike, A. C. Ross (eds). Modern Nutrition in Health and Disease, 9th Edn. Baltimore: Williams and Wilkins, 1999: 3-10.
7. Rudman D., Feller A. Evidence for deficiencies of conditionally essential nutrients during total parenteral nutrition. J Am Coll Nutr 1986; 5: 101-106.
8. Buzzi F. Nuove sperienze fatte sull'occhio umano. Opuscoli Scelti Sulle Scienze e Sulle Arti 1782; 5: 87.
9. Home E. An account of the orifice in the retina of the human eye, discovered by Professor Soemmering. To which are added, proofs of this appearance being extended to the eyes of other animals. Philos Trans R Soc Lond 1798; part 2: 332-345.
10. Soemmering S. De foramine centrali limbo luteo cincto retinae humanae. Comment Soc Reg Sci Goetting 1799; 13: 3.
11. Nussbaum J. J., Pruett R. C., Delori F. C. Macular yellow pigment: the first 200 years. Retina 1981; 1: 296-310.
12. Thudichum J. L. W. Researches conducted for the medical department of the Privy council, at the Pathological Laboratory of St. Thomas's Hospital. Third series. Results of researches on luteine and the spectra of yellow organic substances contained in animals and plants. Proc R Soc Lond 1869; 17: 253-256.
13. Karrer P., Salomon H., Wehrli H. Pflanzenfarbstoffe XIV. Über einen Carotinoidfarbstoff aus Mais: Zeaxanthin. Helv Chim Acta 1929; 12: 790-792.
14. Karrer P., Wehrli H., Helfenstein H. Pflanzenfarbstoffe XIX. Über Zeaxanthin und Xanthophyll. Helv Chim Acta 1930; 13: 268-273.
15. Karrer P., Helfenstein A., Wehrli H., Pieper B., Morf R. Pflanzenfarbstoffe XXX. Beiträge zur Kenntnis des Carotins, der Xanthophylle, des Fucoxanthins und Capsanthins. Helv Chim Acta 1931; 14: 614-632.
16. Karrer P., Morf R., von Krauss E., Zubrys A. Pflanzenfarbstoffe XXXIX. Vermischte Beobachtungen über Carotinoide (α-Carotin, Zeaxanthin, Carotinoide aus Khakifrüchten). Helv Chim Acta 1932; 15: 490-493.
17. Wald G. Human vision and the spectrum. Nature 1945; 101: 653-658.
18. Bone R. A., Landrum J. T., Tarsis S. L. Preliminary identification of the human macular pigment. Vision Res 1985; 25: 1531-1535.
19. Bone R. A., Landrum J. T., Fernandez L., Tarsis S. L. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988; 29: 843-849.
20. Handelman G. J., Dratz E. A., Reay C. C., van Kuijk F. J. G. M. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988; 29: 850-855.
21. Bone R. A., Landrum J. T., Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 1992; 32: 105-110.
22. Landrum J. T., Bone R. A. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001; 385: 28-40.
23. Bone R. A., Landrum J. T., Hime G. W., Cains A., Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993; 34: 2033-2040.
24. Khachik F., Bernstein P. S., Garland D. L. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthal Vis Sci 1997; 38: 1802-1811.
25. Bone R. A., Landrum J. T., Friedes L. M., Gomez C. M., Kilburn M. D., Menendez E. et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997; 64: 211-218.
26. Handelman G. J., Snodderly D. M., Krinsky N. I., Russett M. D., Adler A. J. Biological control of primate macular pigment. Invest Ophthalmol Vis Sci 1991; 32: 257-267.
27. Snodderly D. M., Brown P. K., Delori F. C., Auran J. D. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984; 25: 660-673.
28. Snodderly D. M., Auran J. D., Delori F. C. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 1984; 25: 674-685.
29. Bone R. A., Landrum J. T., Dixon Z., Chen Y., Llerena C. M. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 2000; 71: 239-245.
30. Chan C., Leung I., Lam K. W., Tso M. O. M. The occurrence of retinol and carotenoids in human subretinal fluid. Curr Eye Res 1998; 17: 890-895.
31. Bernstein P. S., Khachik F., Carvalho L. S., Muir G. J., Zhao E. Y., Katz N. B. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001; 72: 215-223.
32. Bernstein P. S., Balashov N. A., Tsong E. D., Rando R. R. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 1997; 38: 167-175.
33. Crabtree D. V., Ojima I., Geng X., Adler A. J. Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem 2001; 9: 1967-1976.
34. Sommerburg O. G., Siems W. G., Hurst J. S., Lewis J. W., Kliger D. S., van Kuijk F. J. G. M. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 1999; 19: 491-495.
35. Rapp L. M., Maple S. S., Choi J. H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 2000; 41: 1200-1209.
36. Brown P. K., Wald G. Visual pigments in human and monkey retinas. Nature 1963; 200: 37-43.
37. Putting B. J., Zweypfennig R. C. V. J., Vrensen G. F. J. M., Oosterhuis J. A., van Best J. A. Blood-retinal barrier dysfunction at the pigment epithelium induced by blue light. Invest Ophthalmol Vis Sci 1992; 33: 3385-3393.
38. Krinsky N. I., Rock C. L. Carotenoids: chemistry, sources and physiology. In: M. J. Sadler, J. J. Strain, B. Caballero (eds). Encyclopedia of Human Nutrition; vol. 1. San Diego: Academic Press, 1999: 304-314.
39. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995; 9: 1551-1558.
40. Frank H. A. Physical and chemical properties of carotenoids. In: L. M. Canfield, N. I. Krinsky, J. A. Olson (eds). Carotenoids in Human Health. Ann N Y Acad Sci; 691. 1993: 1-9.
41. Foote C. S., Denny R. W. Chemistry of singlet oxygen. VII. Quenching by β-carotene. J Am Chem Soc 1968; 90: 6233-6235.
42. Stahl W., Sies H. Physical quenching of singlet oxygen and cis-trans isomerization of carotenoids. Ann N Y Acad Sci 1993; 691: 10-19.
43. Rozanowska M. B., Wrona M., Sarna T., Land E. J., Edge R., Truscott T. G. Interaction of carotenoids with other antioxidants in protection of the retina against oxidative damage (ARVO Abstract #3193). Invest Ophthalmol Vis Sci 2000; 41: S601.
44. Mathews-Roth M. M., Wilson T., Fujimori E., Krinsky N. I. Carotenoid chromophore length and protection against photosensitization. Photochem Photobiol 1974; 19: 217-222.
45. Schalch W., Dayhaw-Barker P., Barker II F. M. The carotenoids of the human retina. In: A. Taylor (ed). Nutritional and Environmental Influences on the Eye. Boca Raton: CRC Press, 1999: 215-250.
46. Burton G. W., Ingold K. U. Beta-carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569-573.
47. Krinsky N. I., Deneke S. M. Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 1982; 69: 205-210.
48. Liebler D. C. Antioxidant reactions of carotenoids. Ann NYAcad Sci 1993; 691: 20-31.
49. Reading V. M., Weale R. A. Macular pigment and chromatic aberration. J Opt Soc Am 1974; 64: 231-234.
50. Hammond B. R., Jr, Wooten B. R., Curran-Celentano J. Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 2001; 385: 41-46.
51. Goldberg J., Flowerdew G., Smith E., Brody J. A., Tso M. O. M. Factors associated with age-related macular degeneration. An analysis of data from the first national health and nutrition examination survey. Am J Epidemiol 1988; 128: 700-710.
52. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701-1708.
53. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993; 111: 104-109.
54. Bone R. A., Landrum J. T., Mayne S. T., Gomez C. M., Tibor S. E., Rwaroska E. E. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001; 42: 235-240.
55. Wooten B. R., Hammond B. R., Jr, Land R. I., Snodderly D. M. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 1999; 40: 2481-2489.
56. Beatty S., Murray I. J., Henson D. B., Carden D., Koh H. H., Boulton M. E. Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 2001; 42: 439-446.
57. Hammond B. R., Jr, Caruso-Avery M. Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 2000; 41: 1492-1497.
58. Hammond B. R., Jr, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 1992; 33: 350-355.
59. Hammond B. R., Jr, Curran-Celantano J., Judd S., Fuld K., Krinsky N. I., Wooten B. R. et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res 1996; 36: 2001-2012.
60. Hammond B. R., Jr, Wooten B. R., Snodderly D. M. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci 1998; 39: 397-406.
61. Hammond B. R., Wooten B. R., Snodderly D. M. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A 1997; 14: 1187-1196.
62. Hammond B. R., Fuld K., Curran-Celentano J. Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci 1995; 36: 2531-2541.
63. Haegerstrom-Portnoy G. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J Opt Soc Am A 1988; 5: 2140-2144.
64. Wang X. D. Absorption and metabolism of β-carotene. J Am Coll Nutr 1994; 13: 314-325.
65. Malinow M. R., Feeney-Burns L., Peterson L. H., Klein M. L., Neuringer M. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 1980; 19: 857-863.
66. Feeney-Burns L., Neuringer M., Gao C. L. Macular pathology in monkeys fed semipurified diets. Prog Clin Biol Res 1989; 314: 601-622.
67. Hammond B. R., Johnson E. L., Russell R. M., Krinsky N. I., Yeum K. J., Edward R. B. et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997; 38: 1795-1801.
68. Landrum J. T., Bone R. A., Joa H., Kilburn M. D., Moore L. L., Sprague K. E. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997; 65: 57-62.
69. Johnson E. J., Hammond B. R., Yeum K. J., Qin J., Wang X. D., Castaneda C. et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000; 71: 1555-1562.
70. Richer S. Part II. ARMD-pilot (case series) environmental intervention data. J Am Optom Assoc 1999; 70: 24-36.
71. Dagnelie G., Zorge I. S., McDonald T. M. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the internet. Optometry 2000; 71: 147-164.
72. Aleman T. S., Duncan J. L., Bieber M. L., de Castro E., Marks D. A., Gardner L. M. et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci 2001; 42: 1873-1881.
73. Leung I., Tso M., Li W., Lam T. Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. Invest Ophthalmol Vis Sci 2001; 42: 466-471.
74. Bendich A. Carotenoids and the immune response. J Nutr 1989; 119: 112-115.
75. Robison W. G., Jr, Jacot J. L., Katz M. L., Glover J. P. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther 2000; 16: 109-120.
76. Williams D. S., Roberts E. A. Modification of the daily photoreceptor membrane shedding response in vitro by antioxidants. Invest Ophthalmol Vis Sci 1992; 33: 3005-3008.
77. Mares-Perlman J. A., Millen A. E., Ficek T. L., Hankinson S. E. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease: overview. J Nutr 2002; 132: 518S-524S.